An increasing number of genes have been linked to Alzheimer disease over the past decade. Most recently, hyperhomocysteinemia and gene mutations suspected to cause hyperhomocysteinemia have been suggested as possible contributors to Alzheimer disease. The enzyme 5,10-methylenetetrahydrofolate reductase (MTHFR) catalyzes the conversion of 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate, which is the major circulating form of folate and a cofactor in remethylation of homocysteine. Two different mutations, one at base position 677 (C to T transition that results in a """"""""thermolabile"""""""" variant of the MTHFR enzyme) and another at base pair 1298 (A to C transition), are now suspected to lead to increased homocysteine levels and increased risk of Alzheimer disease. In order to study the possible role of these gene mutations in Alzheimer disease, we developed practicable PCR-single-strand conformation polymorphism (PCR-SSCP) methods for their study in a large patient population. Both methods have been validated against conventional PCR-restriction fragment-length polymorphism (PCR-RFLP) assays and confirmed by DNA sequencing. In order to analyze the effect of both MTHFR gene mutations on plasma homocysteine, we are also measuring the plasma homocysteine and cysteine levels by an HPLC method in these patients. In another collaborative study, the possible pathogenic role of apolipoprotein(a) isoforms and alleles is being studied in a large cohort of patients with systemic lupus erythematosus. These patients often experience atherothrombotic events and finding reliable predictors for these events is of major clinical importance. Our preliminary findings indicate that apolipoprotetin isoforms/alleles may be such predictors.

Agency
National Institute of Health (NIH)
Institute
Clinical Center (CLC)
Type
Intramural Research (Z01)
Project #
1Z01CL010307-05
Application #
6825480
Study Section
(DLM)
Project Start
Project End
Budget Start
Budget End
Support Year
5
Fiscal Year
2003
Total Cost
Indirect Cost
Name
Clinical Center
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Huey, Edward D; Mirza, Nadeem; Putnam, Karen T et al. (2006) Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients. Dement Geriatr Cogn Disord 22:48-53
Csako, Gyorgy (2006) Foreword. Clin Chim Acta 363:5
Csako, Gyorgy (2006) Present and future of rapid and/or high-throughput methods for nucleic acid testing. Clin Chim Acta 363:6-31
Wu, Yan Yun; Csako, Gyorgy (2006) Rapid and/or high-throughput genotyping for human red blood cell, platelet and leukocyte antigens, and forensic applications. Clin Chim Acta 363:165-76
Sunderland, Trey; Mirza, Nadeem; Putnam, Karen T et al. (2004) Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Biol Psychiatry 56:670-6
Marques, A R; Straus, S E; Fahle, G et al. (2001) Lack of association between HSV-1 DNA in the brain, Alzheimer's disease and apolipoprotein E4. J Neurovirol 7:82-3
Wu, Y Y; Delgado, R; Costello, R et al. (2000) Quantitative assessment of apolipoprotein E genotypes by image analysis of PCR-RFLP fragments. Clin Chim Acta 293:213-21
Wu, Y Y; Delgado, R M; Sunderland, T et al. (2000) Semiautomated PCR-single-strand conformation polymorphism method for detection of a novel sequence polymorphism (Ile1000Val) in human alpha(2)-macroglobulin. Clin Chem 46:715-8
Wu, Y Y; Delgado, R M; Sunderland, T et al. (1999) Detection of a deletion polymorphism of the human alpha(2)-macroglobulin gene (A2M-2) by a semi-automated PCR-single-stranded conformational polymorphism method. Clin Chem 45:1572-3